Platinum-Based Cytostatics Used in Oncology with Respect to Environmental Fate and Innovative Removal Strategies of Their Metabolites

Read full text
Authors: Rafał Olchowski, Kinga Morlo, Ryszard Dobrowolski
Cited by: 3
References: 109

Abstract

Pt complexes have been used in human and veterinary oncology for more than 50 years and represent one of the most significant groups of cytostatics. There are a lot of Pt-based compounds, such as cisplatin, carboplatin and oxaliplatin, which exhibit high efficiency against many tumors. Their broad application in oncology medicine and improper waste disposal induce environmental pollution by platinum cytostatics and their metabolites. They can cause toxic effects to fauna and flora, even at low concentration levels. Currently used technologies for wastewater treatment are not sufficient in the case of platinum-based metabolites. Their high resistance and toxicity of their degradation byproducts pose a serious problem. In this review, currently applied platinum-based cytostatics, their possible metabolic mechanisms, environmental impact and technological methods for their removal from wastewater and patients' urine are summarized. Special attention is paid to adsorption methods.

Fields of Study & Subjects

Chemotherapy-induced organ toxicity mitigation Chemical Reactions and Isotopes Cancer Research and Treatment

Publication details

Journal / source
Molecules
Publisher
MDPI AG
Volume
31
Issue
1
Pages
168–168
Publication date
1 January 2026
Language
EN